Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and insidersCapital raise to ...

TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...

TORONTO - Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has announced the completion of a private placement funding round on February 12, 2025, raising approximately ...

Edesa Biotech, Inc. announced a successful private placement led by Velan Capital, raising approximately $15 million to advance its CXCL10 antibody program through fiscal 2026. The offering ...

Facebook recupera la memoria de dos los cines más queridos de Ponferrada con el hallazgo de imágenes inéditas del día en que ...

As the S&P 500 hovers near record highs and treasury yields drop following retail sales data, investors are keeping a close eye on the broader U.S. market trends. Penny stocks, often associated with ...

Se producen a través de WhatsApp, redes sociales, correos electrónicos y llamadas telefónicas. Desde la empresa solicitan a ...

Edesa Biotech Stock (NASDAQ: EDSA) stock price, news, charts, stock research, profile.

La etíope venció con una marca de 2 horas, 21 minutos y 0 segundos, y encadenó así su segunda victoria consecutiva en esta carrera, tras batir el récord de la misma el año pasado con una marca de 2:18 ...

TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused ...